Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Rochester Medical

This article was originally published in The Gray Sheet

Executive Summary

Rochester Medical: Receives investigational device exemption from FDA to commence clinicals of its FemSoft insert for management of female stress incontinence. The single-use device, which consists of a soft silicone membrane sleeve filled with mineral oil, would be inserted into the urethra to block the flow of urine using a disposable stylette applicator, the firm explains. The insert would be removed for voiding by pulling a silicone tab attached to the device. Submission of a premarket approval application is anticipated in early 1998. If approved, the device would compete with UroMed's Reliance insert for female stress incontinence, which gained FDA approval on Aug. 21...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel